Ester Fernandez Salas
About Ester Fernandez Salas
Ester Fernandez Salas is an Executive Director of R&D Biology with expertise in developing bifunctional and intrinsic degraders. She holds advanced degrees in Biochemistry and Molecular Biology and has extensive experience in leadership roles across various prestigious institutions.
Current Role at Arcus Biosciences
Ester Fernandez Salas currently serves as the Executive Director of R&D Biology at Arcus Biosciences. She has held this position since 2023. In her role, she oversees research and development efforts, focusing on the advancement of innovative drug candidates, particularly in the area of bifunctional and intrinsic degraders.
Professional Experience in Cancer Research
Ester has extensive experience in cancer research, having worked at notable institutions such as MD Anderson Cancer Center and the National Cancer Institute. As a Fulbright fellow at MD Anderson from 1994 to 1996, she contributed to significant research initiatives. At the National Cancer Institute, she served from 1996 to 2000, further enhancing her expertise in oncology.
Education and Expertise in Biochemistry
Ester earned her Bachelor's degree in Biology from Universitat Autònoma de Barcelona, followed by a Master's degree and a Ph.D. in Biochemistry and Molecular Biology from the same institution. Her academic background laid the foundation for her expertise in developing small molecule drugs and her strong skills in patent law.
Leadership and Management Experience
Ester has a proven track record of managing large teams throughout her career. She held leadership positions at Allergan as Senior Director from 2000 to 2013 and at Bristol-Myers Squibb as Senior Principal Scientist from 2018 to 2021. Her managerial capabilities are complemented by her outstanding communication skills, essential for effective collaboration in research and development.
Previous Roles in Research and Development
Before her current role at Arcus Biosciences, Ester served as Senior Director of R&D Biology from 2021 to 2023. She also worked as an Investigator at the University of Michigan from 2013 to 2018. These positions contributed to her extensive knowledge and experience in the field of drug development and biological research.